Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease

Journal of the American Society of Nephrology

Volumn 26, Issue 3, 2015, Pages 677-691

  Zhou, Lili ^a,b   Li, Yingjian ^b   He, Weichun ^b   Zhou, Dong ^b   Tan, Roderick J ^b   Nie, Jing ^a   Hou, Fan Fan ^a   Liu, Youhua ^a,b  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA CATENIN; CALVASCULIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DOXORUBICIN; KLOTHO PROTEIN; MATRILYSIN; NEPHRIN; PODOCALYXIN; PROTEASOME; SYNAPTOPODIN; TRANSCRIPTION FACTOR SNAIL; UBIQUITIN; WNT3A PROTEIN; WT1 PROTEIN; CTNNB1 PROTEIN, MOUSE; MEMBRANE PROTEIN; PAG1 PROTEIN, MOUSE; PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CELL DEDIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY MESENCHYME CELL; MALE; MOUSE; NEPHROBLASTOMA; NONHUMAN; ORGAN CULTURE; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMICALLY INDUCED; METABOLISM; PHYSIOLOGY;

ANIMALS; BETA CATENIN; CELL DEDIFFERENTIATION; CELL LINE; DOXORUBICIN; KIDNEY DISEASES; MALE; MEMBRANE PROTEINS; MICE, INBRED BALB C; PHOSPHOPROTEINS; PODOCYTES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN; WT1 PROTEINS;

EID: 84924060445     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013101067     Document Type: Article

References (46)

1. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006
2. Wiggins RC: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
3. Greka A, Mundel P: Cell biology and pathology of podocytes. Annu Rev Physiol 74: 299-323, 2012
4. Pavenstädt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003
5. Mathieson PW: The podocyte as a target for therapies - new and old. Nat Rev Nephrol 8: 52-56, 2012
6. Patrakka J, Tryggvason K: New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 5: 463-468, 2009
7. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y: Wnt/β-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009
8. He W, Kang YS, Dai C, Liu Y: Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22: 90-103, 2011
9. Kato H, Gruenwald A, Suh JH, Miner JH, Barisoni-Thomas L, Taketo MM, Faul C, Millar SE, Holzman LB, Susztak K: Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem 286: 26003-26015, 2011
10. Heikkilä E, Juhila J, Lassila M, Messing M, Perälä N, Lehtonen E, Lehtonen S, Sjef Verbeek J, Holthofer H: β-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys. Nephrol Dial Transplant 25: 2437-2446, 2010
11. Clevers H, Nusse R: Wnt/β-catenin signaling and disease. Cell 149: 1192-1205, 2012
12. MacDonald BT, Tamai K, He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell 17: 9-26, 2009
13. Angers S, Moon RT: Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10: 468-477, 2009
14. Zhou T, He X, Cheng R, Zhang B, Zhang RR, Chen Y, Takahashi Y, Murray AR, Lee K, Gao G, Ma JX: Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 55: 255-266, 2012
15. Wang D, Dai C, Li Y, Liu Y: Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria. Kidney Int 80: 1159-1169, 2011
16. Zhou L, Li Y, Zhou D, Tan RJ, Liu Y: Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling. J Am Soc Nephrol 24: 771-785, 2013
17. Wagner N, Wagner KD, Xing Y, Scholz H, Schedl A: The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1. J Am Soc Nephrol 15: 3044-3051, 2004
18. Guo G, Morrison DJ, Licht JD, Quaggin SE: WT1 activates a glomerular-specific enhancer identified from the human nephrin gene. J Am Soc Nephrol 15: 2851-2856, 2004
19. Löwik MM, Groenen PJ, Levtchenko EN, Monnens LA, van den Heuvel LP: Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis - a review. Eur J Pediatr 168: 1291-1304, 2009
20. Wang D, Li Y, Wu C, Liu Y: PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression. PLoS ONE 6: e17048, 2011
21. Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA: WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr Biol 11: 1805-1809, 2001
22. Morrison AA, Viney RL, Saleem MA, Ladomery MR: New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol 295: F12-F17, 2008
23. Lahiri D, Dutton JR, Duarte A, Moorwood K, Graham CF, Ward A: Nephropathy and defective spermatogenesis in mice transgenic for a single isoform of the Wilms' tumour suppressor protein, WT1-KTS, together with one disrupted Wt1 allele. Mol Reprod Dev 74: 300-311, 2007
24. Menke AL, IJpenberg A, Fleming S, Ross A, Medine CN, Patek CE, Spraggon L, Hughes J, Clarke AR, Hastie ND: The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis. J Pathol 200: 667-674, 2003
25. Guo JK, Menke AL, Gubler MC, Clarke AR, Harrison D, Hammes A, Hastie ND, Schedl A: WT1 is a key regulator of podocyte function: Reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 11: 651-659, 2002
26. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A: Pathophysiologic implications of reduced podocyte number in a ratmodel of progressive glomerular injury. Am J Pathol 168: 42-54, 2006
27. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ: Inducible rodentmodels of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-F229, 2009
28. He W, Tan R, Dai C, Li Y, Wang D, Hao S, Kahn M, Liu Y: Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/β-catenin signaling. J Biol Chem 285: 24665-24675, 2010
29. He W, Tan RJ, Li Y, Wang D, Nie J, Hou FF, Liu Y: Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD. J Am Soc Nephrol 23: 294-304, 2012
30. Tan R, Zhang J, Tan X, Zhang X, Yang J, Liu Y: Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol 17: 2781-2791, 2006
31. Lecker SH, Goldberg AL, Mitch WE: Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17: 1807-1819, 2006
32. Carmignac V, Quéré R, Durbeej M: Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice. Hum Mol Genet 20: 541-552, 2011
33. Crawford LJ, Walker B, Ovaa H, Chauhan D, Anderson KC, Morris TC, Irvine AE: Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132. Cancer Res 66: 6379-6386, 2006
34. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y: Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172: 299-308, 2008
35. Eguchi M, Nguyen C, Lee SC, Kahn M: ICG-001, a novel small molecule regulator of TCF/β-catenin transcription. Med Chem 1: 467-472, 2005
36. Hao S, He W, Li Y, Ding H, Hou Y, Nie J, Hou FF, Kahn M, Liu Y: Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22: 1642-1653, 2011
37. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ, Gutkind JS, Hwang PM, Finkel T: Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317: 803-806, 2007
38. Su J, Li SJ, Chen ZH, Zeng CH, Zhou H, LiL S, Liu ZH: Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker. Diabetes Res Clin Pract 87: 167-175, 2010
39. Gebeshuber CA, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M, Tauber S, Bilban M, Wang S, Kain R, Böhmig GA, Moeller MJ, Gröne HJ, Englert C, Martinez J, Kerjaschki D: Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med 19: 481-487, 2013
40. Kim MK, McGarry TJ, O Broin P, Flatow JM, Golden AA, Licht JD: An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. Proc Natl Acad Sci U S A 106: 11154-11159, 2009
41. Major MB, Camp ND, Berndt JD, Yi X, Goldenberg SJ, Hubbert C, Biechele TL, Gingras AC, Zheng N, Maccoss MJ, Angers S, Moon RT: Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316: 1043-1046, 2007
42. Kang YS, Li Y, Dai C, Kiss LP, Wu C, Liu Y: Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 78: 363-373, 2010
43. Jiang L, Xu L, Song Y, Li J, Mao J, Zhao AZ, He W, Yang J, Dai C: Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria. J Biol Chem 288: 23368-23379, 2013
44. Zhou L, Li Y, Hao S, Zhou D, Tan RJ, Nie J, Hou FF, Kahn M, Liu Y: Multiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling [published online ahead of print 2014]. J Am Soc Nephrol 10.1681/ASN.2014010085
45. Arking DE, Krebsova A, Macek M Sr., Macek M Jr., Arking A, Mian IS, Fried L, Hamosh A, Dey S, McIntosh I, Dietz HC: Association of human aging with a functional variant of klotho. Proc Natl Acad Sci U S A 99: 856-861, 2002
46. Zhou D, Li Y, Lin L, Zhou L, Igarashi P, Liu Y: Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice. Kidney Int 82: 537-547, 2012